Legal & Planning
TRICARE Changes Policy on ABA Coverage: What You Need to Know
TRICARE is the health insurance program for the Department of Defense (DoD) which covers military personnel and their families. According to Autism Speaks, there are approximately 23,000 military kids with autism.
In late June 2013, TRICARE revised its policies for coverage of Applied Behavior Analysis (ABA). Below is a summary of the major changes set to take effect on July 25. To understand how these changes might affect your child, please review your policy and contact your health insurance representative.
What Programs Are Covered?
Coverage for ABA is available through the following programs:- TRICARE Basic (ABA is considered specialty care)
- Extended Care Health Option (“ECHO”)
- Autism Demonstration program
- ABA Pilot program for non-active duty family members.
What are the Changes to the Programs?
Most notably, TRICARE has restructured the authorization and referral process, which must now go through the TRICARE Basic program. Once treatment is authorized, families can receive hours under any of the programs, including the Autism Demonstration and the ABA Pilot programs. Under the referral and authorization system, parents must get a referral from their primary care physician or from a specialized autism provider. The Managed Care Support Contractor (MCSC) will then refer the family for an ABA assessment, which must include the Autism Diagnostic Observation Scale (ADOS-2) and the Vineland Behavioral Scale (VBS-II). The ADOS is a play and interaction based assessment done by someone with specific training in its scoring and administration. The VBS is a structured interview that covers many different behaviors and activities. Based on the results, the provider can submit a request for authorization of ABA treatment. Part of the referral for authorization of services requires the physician to submit a treatment plan. As part of the treatment plan, the ADOS must be re-done every year and the VBS-II must be done every 180 days in order to reauthorize treatment. The tests are done as a way to track progress on the person’s treatment plan. Some problems of note:- Not all providers are trained in administering the ADOS or VBS so finding providers and the probable waiting list to see those providers could delay access to treatment, especially for those in rural or underserved areas. Add in the burden of frequent re-testing and the potential for delays increases dramatically.
- These tests have not necessarily been validated as a repeated measure to show change over short periods of time. While these measures have been used repeatedly in short time periods in clinical drug trials, using them as a means of tracking progress on a treatment plan has not been established.
- Tests aren't necessarily appropriate for everyone and assessments should be determined by the treating provider and based on the child’s personal strengths and areas targeted for improvement.